tegafur has been researched along with maytansine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carter, SK | 1 |
| Boku, N; Iwatani, T; Kanemaki, Y; Kawamoto, H; Kojima, Y; Motoyoshi, A; Shimo, A; Tsugawa, K; Uejima, T; Yoshie, R | 1 |
1 review(s) available for tegafur and maytansine
| Article | Year |
|---|---|
New drugs under clinical evaluation in the United States.
Topics: Aldehydes; Altretamine; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carmustine; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Humans; Ifosfamide; Maytansine; Streptozocin; Tegafur; Trichothecenes | 1978 |
1 trial(s) available for tegafur and maytansine
| Article | Year |
|---|---|
Trastuzumab Emtansine (T-DM1) Plus S-1 in Patients with Trastuzumab-Pretreated HER2-Positive Advanced or Metastatic Breast Cancer: A Phase Ib Study.
Topics: Ado-Trastuzumab Emtansine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Combinations; Female; Humans; Maytansine; Middle Aged; Neoplasm Metastasis; Oxonic Acid; Receptor, ErbB-2; Tegafur; Trastuzumab; Treatment Outcome | 2019 |